Dow Up 0.51% Nasdaq Up 0.24%

Seattle Genetics Inc. (SGEN)

-NasdaqGS
36.85 Up 0.25(0.68%) Nov 21, 4:00PM EST
|After Hours : 36.85 0.00 (0.00%) Nov 21, 5:00PM EST
Prev Close:36.60
Open:37.13
Bid:16.65 x 100
Ask:N/A
1y Target Est:46.15
Beta:2.47
Earnings Date:Feb 9 - Feb 13 (Est.)
Day's Range:36.42 - 37.80
52wk Range:30.80 - 55.99
Volume:1,037,451
Avg Vol (3m):1,118,550
Market Cap:4.57B
P/E (ttm):N/A
EPS (ttm):-0.53
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
SGENUp 0.68%4.57B
IMGNUp 1.65%845.60M
PFEUp 0.03%191.86B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):16.20
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.66
Quarterly EPS Est (Dec-14) :-0.25
Mean Recommendation*:2.4
PEG Ratio (5 yr expected):-5.49

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Seattle Genetics, Inc., a biotechnology company, develops and commercializes antibody-based therapies for the treatment of cancer. The company is developing antibody-drug conjugates (ADCs), a technology designed to harness the targeting ability of... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback